市場調査レポート
商品コード
1482347

ボツリヌス毒素市場規模・予測、世界・地域シェア、動向、成長機会分析レポート:製品別、用途別、エンドユーザー別、地域別

Botulinum Toxin Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 381 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=159.16円
ボツリヌス毒素市場規模・予測、世界・地域シェア、動向、成長機会分析レポート:製品別、用途別、エンドユーザー別、地域別
出版日: 2024年05月02日
発行: The Insight Partners
ページ情報: 英文 381 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

弊社の最新調査レポート「ボツリヌス毒素の2031年までの市場予測-世界の分析-製品別、用途別、エンドユーザー別」によると、2023年の市場規模は73億8,000万米ドルで、2030年には190億3,000万米ドルに達すると予測されています。2023~2031年のCAGRは12.6%と推定されます。

ボツリヌス毒素は、ボツリヌス菌によって産生される神経毒です。ボツリヌス毒素を筋肉に注射すると、筋肉への神経信号が遮断され、筋肉の収縮が阻害され、不要な表情じわや特徴が軽減されます。ボトックスやディスポートなどのボツリヌス毒素注射は、シワの原因となる筋肉を弛緩させることで見た目を改善します。これらの注射は、偏頭痛、多汗症、過活動膀胱、目の問題なども治療します。

ボツリヌス毒素、カルシウムハイドロキシルアパタイト、ヒアルロン酸などの注射を使った非侵襲的な顔の若返り術。これらの施術は副作用が少なく、セルライト、しわ、フェイスライン、不要な脂肪の減少に役立ちます。自然な若返りのコンセプトは、包括的、多層的、三次元的アプローチに基づいており、患者の特定のニーズに応じて、ボリューム拡大、皮膚緩和、再形成、ボリュームの再配置、皮膚の引き締め、表面の再生などの処置において、複数のテクニックと有効成分を組み合わせます。最もよく使われる非外科的顔面処置は、ケミカルピーリング、レーザー皮膚リサーフェイシング、軟組織フィラー、ボトックスです。より大きなリスクを伴う外科的処置とは異なり、低侵襲処置は、より早い回復、より少ない傷跡、限られたストレス、より良い患者満足度を通じて患者に利益をもたらします。さらに、健康、美、グッドエイジングに関する消費者の見方が変化した結果、世界的に美容に対する理解と受容が進んでいます。国際美容外科学会(ISAPS)によると、2021年の非外科的手術件数は2020年と比較して19.9%増加しました。2021年の非外科的手術の総数は1,750万件でした。このように、非侵襲的な美容処置の採用の急増がボツリヌス毒素市場の成長を促進しています。

用途別、ボツリヌス毒素市場洞察

ボツリヌス毒素市場は、用途別に医療と美容に二分されます。医療セグメントは2023年に最大のボツリヌス毒素市場シェアを占め、2023~2031年に13.3%の最高CAGRを記録すると予測されています。医療セグメントはさらに、慢性片頭痛、筋痙攣、過剰反応性膀胱、多汗症、その他に分類されます。美容セグメントはさらに、しかめジワ/グラベラー、額のジワ、カラスの足跡、四角い顎/咬筋、その他に分類されます。ボツリヌス毒素は、慢性片頭痛、痙性障害、頸部ジストニア、起立性調節障害など、さまざまな病状の治療や管理に使用される神経毒です。ボツリヌス毒素の医療応用には、慢性片頭痛、筋痙攣、過活動膀胱、多汗症などがあります。慢性片頭痛は、片側または両側の拍動性頭痛を特徴とする、重度の身体障害神経疾患です。主に、1ヵ月に少なくとも15日間、3ヵ月にわたって頭痛に悩まされると表現されます。ボツリヌス毒素注射は脳性麻痺の治療にも有効で、患者に重度の筋収縮を緩和します。ボツリヌス毒素Aは、慢性腰痛の治療にも有効であることが研究されています。

エンドユーザー別、ボツリヌス毒素市場洞察

タイプ別では、ボツリヌス毒素市場は専門・皮膚科クリニック、病院・クリニック、その他に分類されます。専門・皮膚科クリニックセグメントが2023年に最大の市場シェアを占めました。このセグメントにおけるボツリヌス毒素市場の成長は、患者が専門的な皮膚科治療のニーズのために皮膚科クリニックに傾倒していること、これらのクリニックが迅速かつ効果的なサービスを提供できることに起因しています。これらの患者は通常、専門家による評価と管理を必要とする特定の皮膚疾患を抱えています。皮膚科クリニックで提供されるボツリヌス毒素治療は、このような特定の悩みに対応するよう調整され、皮膚問題の根本的な原因を対象に設計されたカスタマイズ型処方で行われます。美容整形は、ここ10年でより広く行われるようになりました。さらに、低侵襲技術の採用が皮膚科処置の人気に拍車をかけています。ボツリヌス毒素注射、ヒアルロン酸治療、レーザー脱毛、非外科的脂肪減少術、光若返り/IPL(インテンス・パルス・ライト)は、皮膚科クリニックで行われる最も一般的な非外科的美容施術です。

International Society of Aesthetic Plastic Surgery(国際美容整形学会)、National Institute for Health and Care Excellence(国立医療技術評価機構)は、ボツリヌス毒素市場に関する報告書を作成する際に参照した主要二次情報の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • 市場魅力度分析

第3章 調査手法

第4章 ボツリヌス毒素市場情勢

  • イントロダクション
  • PEST分析
  • エコシステム分析
    • バリューチェーンのベンダー一覧

第5章 ボツリヌス毒素市場-主要市場力学

  • 主要市場促進要因
  • 主要市場抑制要因
  • 主要市場機会
  • 今後の動向
  • 促進要因と抑制要因の影響分析

第6章 ボツリヌス毒素市場-世界市場分析

  • ボツリヌス毒素-世界市場概要
  • ボツリヌス毒素の世界市場と2031年までの予測

第7章 ボツリヌス毒素市場:収益分析-製品別、2021~2031年

  • イントロダクション
  • ボツリヌス毒素A
  • ボツリヌス毒素B

第8章 ボツリヌス毒素市場:収益分析-用途別、2021~2031年

  • イントロダクション
  • 医療
  • 美容

第9章 ボツリヌス毒素市場:収益分析-エンドユーザー別、2021~2031年

  • イントロダクション
  • 専門クリニックと皮膚科クリニック
  • 病院とクリニック
  • その他

第10章 ボツリヌス毒素市場-収益分析-地域別、2021~2031年

  • 北米
    • 米国
    • カナダ
    • メキシコ

注:以下の地域/国についても同様の分析が行われます。

  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • その他の欧州
  • アジア太平洋
    • オーストラリア
    • 中国
    • インド
    • 日本
    • 韓国
    • その他のアジア太平洋
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • その他の中東・アフリカ
  • 中南米
    • ブラジル
    • アルゼンチン
    • その他の中南米

第11章 業界情勢

  • 合併と買収
  • 契約、提携、合弁事業
  • 新製品の上市
  • 事業拡大とその他の戦略的展開

第12章 競合情勢

  • 主要参入企業によるヒートマップ分析
  • 企業のポジショニングと集中度

第13章 ボツリヌス毒素市場-主要企業プロファイル

  • AbbVie Inc.
  • Merz Pharma
  • Aquavit Holdings
  • Evolus, Inc
  • Ipsen Pharma
  • Medytox Inc.
  • GALDERMA
  • HUGEL, Inc.
  • Revance Therapeutics Inc
  • Lanzhou Institute of Biological Products Co Ltd

第14章 付録

図表

List Of Tables

  • Table 1.Botulinum Toxin Market Segmentation27
  • Table 2.Nonsurgical Procedures, by Country, 202134
  • Table 3.Global Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical44
  • Table 4.Global Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic45
  • Table 5.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product52
  • Table 6.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application52
  • Table 7.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical52
  • Table 8.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic53
  • Table 9.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User53
  • Table 10.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product55
  • Table 11.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application55
  • Table 12.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical56
  • Table 13.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic56
  • Table 14.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User56
  • Table 15.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product57
  • Table 16.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application58
  • Table 17.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical58
  • Table 18.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic58
  • Table 19.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User59
  • Table 20.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product60
  • Table 21.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application61
  • Table 22.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical61
  • Table 23.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic61
  • Table 24.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User62
  • Table 25.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product65
  • Table 26.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application65
  • Table 27.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical65
  • Table 28.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic66
  • Table 29.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User66
  • Table 30.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product68
  • Table 31.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application68
  • Table 32.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical69
  • Table 33.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic69
  • Table 34.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User70
  • Table 35.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product72
  • Table 36.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application72
  • Table 37.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical72
  • Table 38.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic73
  • Table 39.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User73
  • Table 40.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product74
  • Table 41.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application75
  • Table 42.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical75
  • Table 43.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic75
  • Table 44.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User76
  • Table 45.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product77
  • Table 46.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application78
  • Table 47.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical78
  • Table 48.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic78
  • Table 49.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User79
  • Table 50.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product80
  • Table 51.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application81
  • Table 52.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical81
  • Table 53.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic81
  • Table 54.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User82
  • Table 55.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product83
  • Table 56.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application84
  • Table 57.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical84
  • Table 58.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic85
  • Table 59.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User85
  • Table 60.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product88
  • Table 61.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application88
  • Table 62.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical88
  • Table 63.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic89
  • Table 64.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User89
  • Table 65.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product91
  • Table 66.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application91
  • Table 67.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical92
  • Table 68.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic92
  • Table 69.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User93
  • Table 70.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product95
  • Table 71.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application95
  • Table 72.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical95
  • Table 73.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic96
  • Table 74.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User96
  • Table 75.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product97
  • Table 76.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application98
  • Table 77.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical98
  • Table 78.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic98
  • Table 79.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User99
  • Table 80.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product100
  • Table 81.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application100
  • Table 82.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical101
  • Table 83.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic101
  • Table 84.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User102
  • Table 85.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product103
  • Table 86.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application104
  • Table 87.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical104
  • Table 88.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic104
  • Table 89.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User105
  • Table 90.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product106
  • Table 91.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application107
  • Table 92.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical107
  • Table 93.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic107
  • Table 94.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User108
  • Table 95.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product110
  • Table 96.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application110
  • Table 97.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical111
  • Table 98.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic111
  • Table 99.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User112
  • Table 100.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product113
  • Table 101.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application114
  • Table 102.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical114
  • Table 103.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic114
  • Table 104.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User115
  • Table 105.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product116
  • Table 106.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application117
  • Table 107.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical117
  • Table 108.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic118
  • Table 109.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User118
  • Table 110.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product119
  • Table 111.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application120
  • Table 112.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical120
  • Table 113.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic120
  • Table 114.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User121
  • Table 115.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product123
  • Table 116.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application123
  • Table 117.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical123
  • Table 118.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic124
  • Table 119.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User124
  • Table 120.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product126
  • Table 121.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application126
  • Table 122.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical127
  • Table 123.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic127
  • Table 124.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User128
  • Table 125.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Country128
  • Table 126.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product130
  • Table 127.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application130
  • Table 128.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical130
  • Table 129.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic131
  • Table 130.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User131
  • Table 131.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product132
  • Table 132.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application133
  • Table 133.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical133
  • Table 134.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic133
  • Table 135.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User134
  • Table 136.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Product135
  • Table 137.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Application136
  • Table 138.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Medical136
  • Table 139.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by Aesthetic137
  • Table 140.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million) - by End User137
  • Table 141.Recent Inorganic Growth Strategies in the Medical Ultrasound Flow Meter Market139
  • Table 142.Recent Organic Growth Strategies in the Medical Ultrasound Flow Meter Market139
  • Table 143.Glossary of Terms173

List Of Figures

  • Figure 1.Botulinum Toxin Market Segmentation, by Geography27
  • Figure 2.PEST Analysis32
  • Figure 3.Impact Analysis of Drivers and Restraints36
  • Figure 4.Botulinum Toxin Market Revenue (US$ Million), 2023-203137
  • Figure 5.Global Botulinum Toxin Market, By Geography Forecast Analysis, 2023 & 203138
  • Figure 6.Botulinum Toxin Market Share (%) - by Product (2023 and 2031)39
  • Figure 7.Botulinum Toxin A: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)40
  • Figure 8.Botulinum Toxin B: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)41
  • Figure 9.Botulinum Toxin Market Share (%) - by Application (2023 and 2031)42
  • Figure 10.Medical: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)43
  • Figure 11.Aesthetic: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)44
  • Figure 12.Botulinum Toxin Market Share (%) - by End User (2023 and 2031)46
  • Figure 13.Speciality and Dermatology Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)47
  • Figure 14.Hospitals and Clinics: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)48
  • Figure 15.Others: Botulinum Toxin Market - Revenue and Forecast to 2031 (US$ Million)49
  • Figure 16.North America: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)50
  • Figure 17.North America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)51
  • Figure 18.North America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)54
  • Figure 19.United States: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)55
  • Figure 20.Canada: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)57
  • Figure 21.Mexico: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)60
  • Figure 22.Europe: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)63
  • Figure 23.Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)64
  • Figure 24.Europe: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)67
  • Figure 25.Germany: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)68
  • Figure 26.United Kingdom: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)71
  • Figure 27.France: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)74
  • Figure 28.Italy: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)77
  • Figure 29.Spain: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)80
  • Figure 30.Rest of Europe: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)83
  • Figure 31.Asia Pacific: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)86
  • Figure 32.Asia Pacific: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)87
  • Figure 33.Asia Pacific: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)90
  • Figure 34.Japan: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)91
  • Figure 35.China: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)94
  • Figure 36.India: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)97
  • Figure 37.South Korea: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)100
  • Figure 38.Australia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)103
  • Figure 39.Rest of APAC: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)106
  • Figure 40.Middle East and Africa: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)109
  • Figure 41.Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)110
  • Figure 42.Middle East and Africa: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)112
  • Figure 43.Saudi Arabia: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)113
  • Figure 44.United Arab Emirates: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)116
  • Figure 45.South Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)119
  • Figure 46.Rest of Middle East and Africa: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)122
  • Figure 47.South and Central America: Botulinum Toxin Market, by Key Country - Revenue (2023) (US$ Million)125
  • Figure 48.South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)126
  • Figure 49.South and Central America: Botulinum Toxin Market Breakdown, by Key Countries, 2023 and 2031 (%)128
  • Figure 50.Brazil: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)129
  • Figure 51.Argentina: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)132
  • Figure 52.Rest of South and Central America: Botulinum Toxin Market - Revenue and Forecast to 2031(US$ Million)135
  • Figure 53.Growth Strategies in the Medical Ultrasound Flow Meter Market138
目次
Product Code: TIPRE00027431

According to our latest study on "Botulinum Toxin Market Forecast to 2031 - Global Analysis - by Product, Application, and End User" the market was valued at US$ 7.38 billion in 2023 and is expected to reach US$ 19.03 billion by 2030. It is estimated to register a CAGR of 12.6% from 2023 to 2031.

Botulinum toxins are neurotoxins produced by bacteria named Clostridium botulinum. After the toxin is injected into a muscle, it blocks nerve signals to the muscle, thereby blocking its contraction and reducing unwanted facial lines or features. Botulinum toxin injections such as Botox and Dysport improve the appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems.

Noninvasive procedures of facial rejuvenation using injections of botulinum toxin, calcium hydroxylapatite, and hyaluronic acid, among others. These procedures have minimal side effects and help reduce cellulite, wrinkles, facial lines, and unwanted fat. The concept of natural rejuvenation is based on a comprehensive, multilayered, three-dimensional approach that combines multiple techniques and active ingredients in procedures such as volume enlargement, skin relaxation, reshaping, volume repositioning, skin tightening, and surface renewal, depending on specific needs of patients. The most often used non-surgical face procedures are chemical peels, laser skin resurfacing, soft tissue fillers, and Botox. Unlike surgical procedures that are associated with greater risks, minimally invasive procedures benefit patients through faster recovery, lesser scarring, limited stress, and better patient satisfaction. Moreover, changing consumer views about wellness, beauty, and good aging results in a better understanding and acceptance of aesthetics worldwide. According to the International Society of Aesthetic Plastic Surgery (ISAPS), the number of nonsurgical procedures increased by 19.9% in 2021 compared to 2020. The total number of nonsurgical procedures was 17.5 million in 2021. Thus, an upsurge in the adoption of noninvasive aesthetic procedures is driving the growth of the botulinum toxin market.

.

By Application, Botulinum Toxin Market-Based Insights

The botulinum toxin market, by application, is bifurcated into medical and aesthetic. The medical segment held the largest botulinum toxin market share in 2023 and is anticipated to register the highest CAGR of 13.3% during 2023-2031. The medical segment is further categorized into chronic migraine, muscle spasm, over reactive bladder, hyperhidrosis, and others. The market for the aesthetic segment is further divided into frown lines/ glabellar, forehead lines, crow's feet, square jaw/ masseter, and others. Botulinum toxin is a neurotoxin used to treat and manage various medical conditions, including chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity. Medical applications of botulinum toxin include chronic migraine, muscle spasms, overreactive bladder, and hyperhidrosis. Chronic migraine is a severely disabling neurological disorder characterized by pulsating unilateral or bilateral headaches. It is primarily described as a headache that troubles individuals for at least 15 days per month for three months. Botulinum toxin injections have also been found to be effective in treating cerebral palsy, providing patients with major relief from severe muscle contraction. Botulinum toxin A has also been studied for its effectiveness in treating chronic lower back pain.

By End User, Botulinum Toxin Market-Based Insights

In terms of type, the botulinum toxin market is categorized into specialty and dermatology clinics, hospitals and clinics, and others. The specialty and dermatology clinics segment held the largest market share in 2023. The botulinum toxin market growth in this segment is attributed to the patients' inclination toward dermatology clinics for their specialized dermatology treatment needs, and the ability of these clinics to provide rapid and effective services. These patients usually have specific skin conditions that require expert evaluation and management. Botulinum toxin treatments offered in dermatology clinics are tailored to address these specific concerns, with customized formulations designed to target the underlying causes of skin problems. Cosmetic procedures have become more widespread in the last 10 years. Moreover, the introduction of minimally invasive techniques has added to the popularity of dermatological procedures. Botulinum toxin injections, hyaluronic acid treatments, laser hair removal, nonsurgical fat reduction, and photorejuvenation/intense pulse light (IPL) have been the most common nonsurgical cosmetic procedures that are performed in dermatology clinics.

International Society of Aesthetic Plastic Surgery, and National Institute for Health and Care Excellence are a few of the major secondary sources referred to while preparing the report on the botulinum toxin market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Botulinum Toxin Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Botulinum Toxin Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Botulinum Toxin Market - Global Market Analysis

  • 6.1 Botulinum Toxin - Global Market Overview
  • 6.2 Botulinum Toxin - Global Market and Forecast to 2031

7. Botulinum Toxin Market - Revenue Analysis (USD Million) - By Product, 2021-2031

  • 7.1 Overview
  • 7.2 Botulinum Toxin A
  • 7.3 Botulinum Toxin B

8. Botulinum Toxin Market - Revenue Analysis (USD Million) - By Application, 2021-2031

  • 8.1 Overview
  • 8.2 Medical
    • 8.2.1 Chronic Migraine
    • 8.2.2 Muscle Spasm
    • 8.2.3 Over Reactive Bladder
    • 8.2.4 Hyperhidrosis
    • 8.2.5 Others
  • 8.3 Aesthetic
    • 8.3.1 Crow's Feet
    • 8.3.2 Forehead Lines
    • 8.3.3 Frown Lines/ Glabellar
    • 8.3.4 Square Jaw/ Masseter
    • 8.3.5 Others

9. Botulinum Toxin Market - Revenue Analysis (USD Million) - By End User, 2021-2031

  • 9.1 Overview
  • 9.2 Specialty and Dermatology Clinics
  • 9.3 Hospitals and Clinics
  • 9.4 Others

10. Botulinum Toxin Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Botulinum Toxin Market Overview
    • 10.1.2 North America Botulinum Toxin Market Revenue and Forecasts to 2031
    • 10.1.3 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By Product
    • 10.1.4 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By Application
    • 10.1.5 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Botulinum Toxin Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Botulinum Toxin Market
        • 10.1.6.1.1 United States Botulinum Toxin Market, by Product
        • 10.1.6.1.2 United States Botulinum Toxin Market, by Application
        • 10.1.6.1.3 United States Botulinum Toxin Market, by End User
      • 10.1.6.2 Canada Botulinum Toxin Market
        • 10.1.6.2.1 Canada Botulinum Toxin Market, by Product
        • 10.1.6.2.2 Canada Botulinum Toxin Market, by Application
        • 10.1.6.2.3 Canada Botulinum Toxin Market, by End User
      • 10.1.6.3 Mexico Botulinum Toxin Market
        • 10.1.6.3.1 Mexico Botulinum Toxin Market, by Product
        • 10.1.6.3.2 Mexico Botulinum Toxin Market, by Application
        • 10.1.6.3.3 Mexico Botulinum Toxin Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 U.A.E
    • 10.4.4 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Industry Landscape

  • 11.1 Mergers and Acquisitions
  • 11.2 Agreements, Collaborations, Joint Ventures
  • 11.3 New Product Launches
  • 11.4 Expansions and Other Strategic Developments

12. Competitive Landscape

  • 12.1 Heat Map Analysis by Key Players
  • 12.2 Company Positioning and Concentration

13. Botulinum Toxin Market - Key Company Profiles

  • 13.1 AbbVie Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 13.2 Merz Pharma
  • 13.3 Aquavit Holdings
  • 13.4 Evolus, Inc
  • 13.5 Ipsen Pharma
  • 13.6 Medytox Inc.
  • 13.7 GALDERMA
  • 13.8 HUGEL, Inc.
  • 13.9 Revance Therapeutics Inc
  • 13.10 Lanzhou Institute of Biological Products Co Ltd

14. Appendix

  • 14.1 Glossary
  • 14.2 About The Insight Partners
  • 14.3 Market Intelligence Cloud